HK1041875A1 - Amide derivatives - Google Patents
Amide derivativesInfo
- Publication number
- HK1041875A1 HK1041875A1 HK02103784A HK02103784A HK1041875A1 HK 1041875 A1 HK1041875 A1 HK 1041875A1 HK 02103784 A HK02103784 A HK 02103784A HK 02103784 A HK02103784 A HK 02103784A HK 1041875 A1 HK1041875 A1 HK 1041875A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- halogeno
- aryl
- group
- amide derivatives
- arylamino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/57—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and carboxyl groups, other than cyano groups, bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Dermatology (AREA)
- Otolaryngology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9906277.0A GB9906277D0 (en) | 1999-03-17 | 1999-03-17 | Amide derivatives |
GB0002472A GB0002472D0 (en) | 2000-02-03 | 2000-02-03 | Amide derivatives |
PCT/GB2000/000914 WO2000055120A1 (en) | 1999-03-17 | 2000-03-13 | Amide derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1041875A1 true HK1041875A1 (en) | 2002-07-26 |
Family
ID=26243557
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK02103784A HK1041875A1 (en) | 1999-03-17 | 2002-05-21 | Amide derivatives |
Country Status (23)
Country | Link |
---|---|
US (2) | US6548514B1 (ja) |
EP (1) | EP1163212B1 (ja) |
JP (1) | JP2002539187A (ja) |
KR (1) | KR20010110668A (ja) |
CN (1) | CN100352804C (ja) |
AT (1) | ATE303357T1 (ja) |
AU (1) | AU761291B2 (ja) |
BR (1) | BR0009041A (ja) |
CA (1) | CA2361819A1 (ja) |
CZ (1) | CZ20013276A3 (ja) |
DE (1) | DE60022328T2 (ja) |
DK (1) | DK1163212T3 (ja) |
ES (1) | ES2246830T3 (ja) |
HK (1) | HK1041875A1 (ja) |
HU (1) | HUP0105136A3 (ja) |
IL (1) | IL145277A0 (ja) |
NO (1) | NO20014488L (ja) |
NZ (1) | NZ513726A (ja) |
PL (1) | PL350448A1 (ja) |
RU (1) | RU2284187C2 (ja) |
SK (1) | SK13132001A3 (ja) |
TR (1) | TR200102568T2 (ja) |
WO (1) | WO2000055120A1 (ja) |
Families Citing this family (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7772432B2 (en) | 1991-09-19 | 2010-08-10 | Astrazeneca Ab | Amidobenzamide derivatives which are useful as cytokine inhibitors |
GB9816837D0 (en) | 1998-08-04 | 1998-09-30 | Zeneca Ltd | Amide derivatives |
CN1271279A (zh) | 1997-09-23 | 2000-10-25 | 普尼卡有限公司 | 用于治疗细胞因子介导性疾病的酰胺类衍生物 |
CN1185211C (zh) | 1998-05-15 | 2005-01-19 | 阿斯特拉曾尼卡有限公司 | 用于治疗由细胞活素引起的疾病的苯甲酰胺衍生物 |
KR100628284B1 (ko) | 1998-05-15 | 2006-09-27 | 아스트라제네카 아베 | 시토킨 매개 질환 치료용 벤즈아미드 유도체 |
HUP0103019A3 (en) | 1998-08-04 | 2002-01-28 | Astrazeneca Ab | Amide derivatives useful as inhibitors of the production of cytokines, process for producing them and pharmaceutical compositions containing them |
IL141979A0 (en) | 1998-09-25 | 2002-03-10 | Astrazeneca Ab | Benzamide derivatives and their use as cytokine inhibitors |
DK1163237T3 (da) | 1999-03-17 | 2004-08-02 | Astrazeneca Ab | Amidderivater |
GB9906566D0 (en) | 1999-03-23 | 1999-05-19 | Zeneca Ltd | Chemical compounds |
GB9924092D0 (en) | 1999-10-13 | 1999-12-15 | Zeneca Ltd | Pyrimidine derivatives |
US6943161B2 (en) | 1999-12-28 | 2005-09-13 | Pharmacopela Drug Discovery, Inc. | Pyrimidine and triazine kinase inhibitors |
KR100407640B1 (ko) * | 2000-12-19 | 2003-12-01 | 주식회사 태평양 | 신규한 디페닐 아미드 유도체, 그의 제조방법 및 이를포함하는 약학 및 화장료 조성물 |
JP2002338537A (ja) * | 2001-05-16 | 2002-11-27 | Mitsubishi Pharma Corp | アミド化合物およびその医薬用途 |
AU2002350172A1 (en) * | 2001-12-07 | 2003-06-23 | Eli Lilly And Company | Substituted heterocyclic carboxamides with antithrombotic activity |
EP1707205A2 (en) | 2002-07-09 | 2006-10-04 | Boehringer Ingelheim Pharma GmbH & Co. KG | Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases |
EP1651606B1 (en) * | 2003-07-30 | 2012-10-24 | Xenon Pharmaceuticals Inc. | Pyridyl derivatives and their use as therapeutic agents |
MXPA06002853A (es) * | 2003-09-11 | 2006-06-14 | Kemia Inc | Inhibidores citoquina. |
GB0324790D0 (en) | 2003-10-24 | 2003-11-26 | Astrazeneca Ab | Amide derivatives |
BR122015027139B1 (pt) | 2004-01-28 | 2016-05-10 | Mitsui Chemicals Inc | compostos derivados de amida, inseticida compreendendo os mesmos e método de uso dos mesmos como inseticida |
US20060035893A1 (en) | 2004-08-07 | 2006-02-16 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders |
DE102005023834A1 (de) * | 2004-11-20 | 2006-05-24 | Bayer Healthcare Ag | Substituierte[(Phenylethanoyl)amino]benzamide |
CN101128454A (zh) * | 2004-12-22 | 2008-02-20 | 阿斯利康(瑞典)有限公司 | 用作抗癌药物的吡啶羧酰胺衍生物 |
AR053992A1 (es) * | 2004-12-22 | 2007-05-30 | Astrazeneca Ab | Compuestos quimicos con actividad anticancerosa, un procedimiento para su preparacion, su uso en la preparacion de medicamentos y composicion farmaceutica. |
PE20060777A1 (es) | 2004-12-24 | 2006-10-06 | Boehringer Ingelheim Int | Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas |
US7759337B2 (en) * | 2005-03-03 | 2010-07-20 | Amgen Inc. | Phthalazine compounds and methods of use |
DE602006016430D1 (de) * | 2005-05-03 | 2010-10-07 | Ranbaxy Lab Ltd | Phosphodiesteraseinhibitoren auf azolbasis |
WO2006137376A1 (ja) | 2005-06-21 | 2006-12-28 | Mitsui Chemicals, Inc. | アミド誘導体ならびに該化合物を含有する殺虫剤 |
TW200740370A (en) * | 2005-06-23 | 2007-11-01 | Mitsui Chemicals Inc | Amide derivative, pesticide containing such compound and use thereof |
DE602006000082T2 (de) * | 2005-07-07 | 2008-05-15 | Rohm And Haas Co. | Faser mit antimikrobiell wirksamer Zusammensetzung |
JP4580836B2 (ja) * | 2005-07-25 | 2010-11-17 | 三井化学アグロ株式会社 | 殺虫殺菌組成物 |
MX302893B (es) | 2005-07-27 | 2012-08-30 | Mitsui Chemicals Inc | Composicion para control de pestes. |
US7754717B2 (en) * | 2005-08-15 | 2010-07-13 | Amgen Inc. | Bis-aryl amide compounds and methods of use |
EP2038289A2 (en) * | 2006-04-21 | 2009-03-25 | Amgen Inc. | Thieno-[2,3-d]pyrimidine and thieno-pyridazine compounds and methods of use |
WO2008011032A1 (en) * | 2006-07-17 | 2008-01-24 | Amgen Inc. | Quinazoline and pyridopyrimidine derivatives as p38 kinase inhibitors |
ATE501124T1 (de) * | 2006-09-05 | 2011-03-15 | Amgen Inc | Phthalazin-, aza- und diazaphthalazinverbindungen und anwendungsverfahren |
US8466180B2 (en) | 2006-09-11 | 2013-06-18 | Syngenta Crop Protection Llc | Insecticidal compounds |
WO2008045393A2 (en) * | 2006-10-11 | 2008-04-17 | Amgen Inc. | Imidazo- and triazolo-pyridine compounds and methods of use therof |
WO2008057775A2 (en) * | 2006-10-27 | 2008-05-15 | Bristol-Myers Squibb Company | Heterocyclic amide compounds useful as kinase inhibitors |
EP2152706A1 (en) | 2007-05-07 | 2010-02-17 | Amgen Inc. | Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as p38 modulators, process for their preparation, and their pharmaceutical use |
EP1992344A1 (en) | 2007-05-18 | 2008-11-19 | Institut Curie | P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation |
WO2009038784A1 (en) * | 2007-09-21 | 2009-03-26 | Amgen Inc. | Triazole fused heteroaryl compounds as p38 kinase inhibitors |
WO2010025201A1 (en) | 2008-08-29 | 2010-03-04 | Amgen Inc. | Pyridazino- pyridinone compounds for the treatment of protein kinase mediated diseases. |
EP2334673A1 (en) | 2008-08-29 | 2011-06-22 | Amgen Inc. | PYRIDO[3,2-d]PYRIDAZINE-2(1H)-ONE COMPOUNDS AS P38 MODULATORS AND METHODS OF USE THEREOF |
US8497269B2 (en) | 2008-10-10 | 2013-07-30 | Amgen Inc. | Phthalazine compounds as p38 map kinase modulators and methods of use thereof |
US8772481B2 (en) | 2008-10-10 | 2014-07-08 | Amgen Inc. | Aza- and diaza-phthalazine compounds as P38 map kinase modulators and methods of use thereof |
GB0902648D0 (en) * | 2009-02-17 | 2009-04-01 | Argenta Discovery Ltd | Pharmaceutical compounds and compositions |
US9452980B2 (en) * | 2009-12-22 | 2016-09-27 | Hoffmann-La Roche Inc. | Substituted benzamides |
UY34305A (es) | 2011-09-01 | 2013-04-30 | Novartis Ag | Derivados de heterociclos bicíclicos para el tratamiento de la hipertensión arterial pulmonar |
US9073921B2 (en) | 2013-03-01 | 2015-07-07 | Novartis Ag | Salt forms of bicyclic heterocyclic derivatives |
EP2976327B1 (en) * | 2013-03-20 | 2017-06-21 | Bayer Pharma Aktiengesellschaft | 3-acetylamino-1-(phenyl-heteroaryl-aminocarbonyl or phenyl-heteroaryl-carbonylamino)benzene derivatives for the treatment of hyperproliferative disorders |
JP2016521259A (ja) | 2013-03-20 | 2016-07-21 | バイエル・ファルマ・アクティエンゲゼルシャフト | 置換N−ビフェニル−3−アセチルアミノ−ベンズアミドおよびN−[3−(アセチルアミノ)フェニル]−ビフェニル−カルボキサミドならびにWntシグナル伝達経路の阻害剤としてのそれらの使用 |
PT3083554T (pt) * | 2013-12-17 | 2019-06-11 | Lilly Co Eli | Compostos de ácido dimetilbenzóico |
AP2016009432A0 (en) * | 2014-03-20 | 2016-09-30 | Bayer Pharma AG | Novel compounds |
EP3119787A1 (en) * | 2014-03-20 | 2017-01-25 | Bayer Pharma Aktiengesellschaft | Inhibitors of the wnt signalling pathways |
WO2016029136A1 (en) * | 2014-08-21 | 2016-02-25 | Northwestern University | 3-amidobenzamides and uses thereof for increasing cellular levels of a3g |
JP2018507212A (ja) | 2015-02-20 | 2018-03-15 | バイエル・ファルマ・アクティエンゲゼルシャフト | N−フェニル−(モルホリン−4−イルまたはピペラジニル)アセトアミド誘導体およびwntシグナル伝達経路の阻害剤としてのその使用 |
JP2018505906A (ja) | 2015-02-20 | 2018-03-01 | バイエル・ファルマ・アクティエンゲゼルシャフト | Wntシグナル伝達経路の阻害剤としての1,3,4−チアジアゾール−2−イル−ベンズアミド誘導体 |
CN107531634A (zh) | 2015-02-20 | 2018-01-02 | 拜耳制药股份公司 | 作为wnt信号通路抑制剂的3‑氨基甲酰基苯基‑4‑甲酰胺和间苯二甲酰胺衍生物 |
WO2017151409A1 (en) | 2016-02-29 | 2017-09-08 | University Of Florida Research Foundation, Incorporated | Chemotherapeutic methods |
AU2017234042B2 (en) | 2016-03-17 | 2020-11-19 | F. Hoffmann-La Roche Ag | 5-ethyl-4-methyl-pyrazole-3-carboxamide derivative having activity as agonist of TAAR |
TWI794171B (zh) | 2016-05-11 | 2023-03-01 | 美商滬亞生物國際有限公司 | Hdac抑制劑與pd-l1抑制劑之組合治療 |
TWI808055B (zh) | 2016-05-11 | 2023-07-11 | 美商滬亞生物國際有限公司 | Hdac 抑制劑與 pd-1 抑制劑之組合治療 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE522788C (de) * | 1928-11-01 | 1931-04-15 | I G Farbenindustrie Akt Ges | Verfahren zur Darstellung von Carbonsaeurearyliden der Benzolreihe |
NL129433C (ja) * | 1963-09-21 | |||
GB9413975D0 (en) * | 1994-07-11 | 1994-08-31 | Fujisawa Pharmaceutical Co | New heterobicyclic derivatives |
CA2020887A1 (en) * | 1989-07-28 | 1991-01-29 | Michael Klaus | Aromatic carboxylic amides |
GB9816837D0 (en) * | 1998-08-04 | 1998-09-30 | Zeneca Ltd | Amide derivatives |
GB9307956D0 (en) * | 1993-04-17 | 1993-06-02 | Walls Alan J | Hydroxamic acid derivatives |
WO1996025157A1 (en) * | 1995-02-17 | 1996-08-22 | Smithkline Beecham Corporation | Il-8 receptor antagonists |
AU6709596A (en) * | 1995-08-22 | 1997-03-19 | Japan Tobacco Inc. | Amide compounds and use of the same |
JPH09124571A (ja) * | 1995-11-01 | 1997-05-13 | Japan Tobacco Inc | アミド化合物及びその用途 |
GB9623833D0 (en) | 1996-11-16 | 1997-01-08 | Zeneca Ltd | Chemical compound |
CN1271279A (zh) | 1997-09-23 | 2000-10-25 | 普尼卡有限公司 | 用于治疗细胞因子介导性疾病的酰胺类衍生物 |
CN1185211C (zh) | 1998-05-15 | 2005-01-19 | 阿斯特拉曾尼卡有限公司 | 用于治疗由细胞活素引起的疾病的苯甲酰胺衍生物 |
KR100628284B1 (ko) | 1998-05-15 | 2006-09-27 | 아스트라제네카 아베 | 시토킨 매개 질환 치료용 벤즈아미드 유도체 |
HUP0103019A3 (en) | 1998-08-04 | 2002-01-28 | Astrazeneca Ab | Amide derivatives useful as inhibitors of the production of cytokines, process for producing them and pharmaceutical compositions containing them |
IL141979A0 (en) | 1998-09-25 | 2002-03-10 | Astrazeneca Ab | Benzamide derivatives and their use as cytokine inhibitors |
PT1117653E (pt) | 1998-10-01 | 2003-06-30 | Astrazeneca Ab | Derivados de quinolina e quinazolina e sua utilizacao como inibidores de doencas mediadas pela citosina |
DK1163237T3 (da) | 1999-03-17 | 2004-08-02 | Astrazeneca Ab | Amidderivater |
GB9906566D0 (en) | 1999-03-23 | 1999-05-19 | Zeneca Ltd | Chemical compounds |
GB9924092D0 (en) | 1999-10-13 | 1999-12-15 | Zeneca Ltd | Pyrimidine derivatives |
-
2000
- 2000-03-13 BR BR0009041-7A patent/BR0009041A/pt not_active IP Right Cessation
- 2000-03-13 JP JP2000605551A patent/JP2002539187A/ja active Pending
- 2000-03-13 EP EP00909500A patent/EP1163212B1/en not_active Expired - Lifetime
- 2000-03-13 CA CA002361819A patent/CA2361819A1/en not_active Abandoned
- 2000-03-13 DE DE60022328T patent/DE60022328T2/de not_active Expired - Fee Related
- 2000-03-13 CN CNB008051283A patent/CN100352804C/zh not_active Expired - Fee Related
- 2000-03-13 SK SK1313-2001A patent/SK13132001A3/sk unknown
- 2000-03-13 IL IL14527700A patent/IL145277A0/xx unknown
- 2000-03-13 RU RU2001128067/04A patent/RU2284187C2/ru not_active IP Right Cessation
- 2000-03-13 HU HU0105136A patent/HUP0105136A3/hu unknown
- 2000-03-13 US US09/936,698 patent/US6548514B1/en not_active Expired - Fee Related
- 2000-03-13 PL PL00350448A patent/PL350448A1/xx not_active Application Discontinuation
- 2000-03-13 TR TR2001/02568T patent/TR200102568T2/xx unknown
- 2000-03-13 AU AU31780/00A patent/AU761291B2/en not_active Ceased
- 2000-03-13 NZ NZ513726A patent/NZ513726A/en unknown
- 2000-03-13 AT AT00909500T patent/ATE303357T1/de not_active IP Right Cessation
- 2000-03-13 ES ES00909500T patent/ES2246830T3/es not_active Expired - Lifetime
- 2000-03-13 WO PCT/GB2000/000914 patent/WO2000055120A1/en active Search and Examination
- 2000-03-13 DK DK00909500T patent/DK1163212T3/da active
- 2000-03-13 KR KR1020017011738A patent/KR20010110668A/ko not_active Application Discontinuation
- 2000-03-13 CZ CZ20013276A patent/CZ20013276A3/cs unknown
-
2001
- 2001-09-14 NO NO20014488A patent/NO20014488L/no not_active Application Discontinuation
-
2002
- 2002-05-21 HK HK02103784A patent/HK1041875A1/xx not_active IP Right Cessation
-
2003
- 2003-01-29 US US10/353,127 patent/US6794380B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
RU2001128067A (ru) | 2004-01-20 |
AU3178000A (en) | 2000-10-04 |
ATE303357T1 (de) | 2005-09-15 |
ES2246830T3 (es) | 2006-03-01 |
AU761291B2 (en) | 2003-05-29 |
CZ20013276A3 (cs) | 2001-12-12 |
US20030186966A1 (en) | 2003-10-02 |
PL350448A1 (en) | 2002-12-16 |
NO20014488L (no) | 2001-11-14 |
TR200102568T2 (tr) | 2002-05-21 |
NZ513726A (en) | 2001-09-28 |
US6548514B1 (en) | 2003-04-15 |
KR20010110668A (ko) | 2001-12-13 |
EP1163212B1 (en) | 2005-08-31 |
CA2361819A1 (en) | 2000-09-21 |
DE60022328D1 (de) | 2005-10-06 |
HUP0105136A3 (en) | 2002-05-28 |
US6794380B2 (en) | 2004-09-21 |
CN100352804C (zh) | 2007-12-05 |
DE60022328T2 (de) | 2006-06-01 |
DK1163212T3 (da) | 2005-11-14 |
NO20014488D0 (no) | 2001-09-14 |
EP1163212A1 (en) | 2001-12-19 |
SK13132001A3 (sk) | 2002-02-05 |
BR0009041A (pt) | 2001-12-26 |
HUP0105136A2 (hu) | 2002-04-29 |
JP2002539187A (ja) | 2002-11-19 |
IL145277A0 (en) | 2002-06-30 |
WO2000055120A1 (en) | 2000-09-21 |
CN1344249A (zh) | 2002-04-10 |
RU2284187C2 (ru) | 2006-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL145277A0 (en) | Amide derivatives | |
MY128501A (en) | Amide derivatives | |
DE60017279D1 (en) | Pyrimidinderivate | |
HUT60250A (en) | Process for producing new phenylimidazolidines, their thione and iminoderivatives, and pharmaceutical compositions comprising same as active ingredient | |
PL346854A1 (en) | Benzamide derivatives and their use as cytokine inhibitors | |
HK1037367A1 (en) | Quinoline and quinazoline derivatives and their use as inhibitors of cytokine mediated diseases | |
NZ509318A (en) | Amide derivatives, their preparation and use in the treatment of diseases mediated by cytokines | |
ATE355064T1 (de) | Dihydroxypyrimidin-carbonsäueramid-hemmer der hiv-integrase | |
MY141661A (en) | 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
RS99203A (en) | Pyrrolopyrimidines as protein kinase inhibitors | |
MY102689A (en) | 4-amino-3-carbonyl substituted quinolines | |
DE60036812D1 (de) | Chinazolin derivate | |
DE60014393D1 (de) | Aminobenzophenone als inhibitoren von il-1beta und tnf-alpha | |
MXPA03011998A (es) | Pirrolopirimidinas como inhibidores de protein cinasa. | |
MXPA03008215A (es) | Inhibidores de integrina alfa v beta 6. | |
MX9605458A (es) | Derivados de amida y su uso terapeutico. | |
IL131216A (en) | Drugs inhibiting progress of pterygium and postoperative recurrence of the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20100313 |